Improvement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration

Cancer Cytopathology

Volumn 120, Issue 3, 2012, Pages 185-195

  Yung, Rex Chin Wei ^a   Otell, Susan ^b   Illei, Peter ^b   Clark, Douglas P ^b   Feller Kopman, David ^a   Yarmus, Lonny ^a   Askin, Frederic ^b   Gabrielson, Edward ^b   Li, Qing Kay ^a,b  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cell block preparation; Endobronchial ultrasound guided transbronchial fine needle aspiration (EBUS TBNA); Fine needle aspiration cytology; Improvement of cellularity; Lung cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOBRONCHIAL ULTRASOUND GUIDED TRANSBRONCHIAL FINE NEEDLE ASPIRATION; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LUNG LESION; LUNG NON SMALL CELL CANCER; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; SALINE RINSE CELL BLOCK; TISSUE COAGULUM CLOT CELL BLOCK; TRANSBRONCHIAL ASPIRATION; BRONCHOSCOPY; CANCER INVASION; CANCER STAGING; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; COMPARATIVE STUDY; CYTODIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; LABORATORY DIAGNOSIS; LUNG TUMOR; LYMPH NODE; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; SENSITIVITY AND SPECIFICITY; TISSUE FIXATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; BRONCHOSCOPY; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CYTODIAGNOSIS; ENDOSONOGRAPHY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TISSUE FIXATION;

EID: 84864744400     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20199     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Rami-Porta R, Ball D, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007; 2:593-602.
3. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res. 2004;64:8919-8923.
4. Chen HY, Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med. 2007;356:11-20.
5. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004;304:1497-1500.
6. Lee W, Jiang Z, Liu J, et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature. 2010;465:473-477.
7. Rosell R, Moran T, Queralt C, et al Spanish Lung Cancer Group. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med. 2009;361:958-967.
8. Ganti AK, Huang CH, Klein MA, Keefe S, Kelley MJ. Lung cancer management in 2010. Oncology (Williston Park). 2011;25:64-73.
9. Pao W, Girard N. New driver mutations in non-small-cell lung cancer. Lancet Oncol. 2011;12:175-180.
10. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advancedstage non-small-cell lung cancer. J Clin Oncol. 2008;26: 3543-3551.
11. Scagliotti GV, Germonpre P, Bosquee L, et al. A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer. Lung Cancer. 2010; 68:420-426.
12. Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361:947-957.
13. Hirsch FR, Wynes MW, Gandara DR, Bunn PA Jr. The tissue is the issue: personalized medicine for non-small cell lung cancer. Clin Cancer Res. 2010;16:4909-4911.
14. Cagle PT, Allen TC, Dacic S, et al. Revolution in lung cancer: new challenges for the surgical pathologist. Arch Pathol Lab Med. 2011;135:110-116.
15. Yasufuku K, Chiyo M, Sekine Y, et al. Real-Time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest. 2004; 126:122-128.
16. Jacob-Ampuero MP, Haas AR, Ciocca V, Bibbo M. Cytologic accuracy of samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration at Thomas Jefferson University Hospital. Acta Cytol. 2008; 52:687-690.
17. Alsharif M, Andrade RS, Groth SS, Stelow EB, Pambuccian SE. Endobronchial ultrasound-guided transbronchial fine-needle aspiration: the University of Minnesota experience, with emphasis on usefulness, adequacy assessment, and diagnostic difficulties. Am J Clin Pathol. 2008;130: 434-443.
18. Feller-Kopman D, Yung RCW, Burroughs F, Li QK. Cytology of endobronchial ultrasound-guided transbronchial needle aspiration: a retrospective study with histology correlation. Cancer Cytopathol. 2009;117:482-490.
19. Stoll LM, Yung RC, Clark DP, Li QK. Cytology of endobronchial ultrasound-guided transbronchial needle aspiration versus conventional transbronchial needle aspiration. Cancer Cytopathol. 2010;118:278-286.
20. Sun W, Song K, Zervos M, et al. The diagnostic value of endobronchial ultrasound-guided needle biopsy in lung cancer and mediastinal adenopathy. Diagn Cytopathol. 2010; 38:337-342.
21. Lam WK, So SY, Hsu C, Yu DY. Fibreoptic bronchoscopy in the diagnosis of bronchial cancer: comparison of washings, brushings and biopsies in central and peripheral tumours. Clin Oncol. 1983;9:35-42.
22. Mak VH, Johnston ID, Hetzel MR, Grubb C. Value of washings and brushings at fibreoptic bronchoscopy in the diagnosis of lung cancer. Thorax. 1990;45:373-376.
23. Yung RC. Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy. Respir Care Clin N Am. 2003;9:51-76.
24. Karnauchow PN, Bonin RE. "Cell-block" technique for fine needle aspiration biopsy. J Clin Pathol. 1982;35:688.
25. Burt AD, Smillie D, Cowan MD, Adams FG. Fine needle aspiration cytology: experience with a cell block technique. J Clin Pathol. 1986;39:114-115.
26. Olson NJ, Gogel HK, Williams WL, Mettler FA Jr. Processing of aspiration cytology samples. An alternative method. Acta Cytol. 1986;30:409-412.
27. Rosell A, Monso E, Lores L, et al. Cytology of bronchial biopsy rinse fluid to improve the diagnostic yield for lung cancer. Eur Respir J. 1998;12:1415-1418.
28. Maldonado F, Jett Jr. Advances in the diagnosis of lung cancer: contribution of molecular biology to bronchoscopic diagnosis. Curr Opin Pulm Med. 2010;16:315-320.
29. Constantian HM, De Girolami E. Urothelial tumors detected by cytology: new cell block technique. J Urol. 1973; 109:304-307.
30. De Girolami E. Applications of plasma-Thrombin cell block in diagnostic cytology, Part II: II: digestive and respiratory tracts, breast and effusions. Pathol Annu. 1977;12(pt 2):91-110.
31. Kulkarni MB, Desai SB, Ajit D, Chinoy RF. Utility of the thromboplastin-plasma cell-block technique for fine-needle aspiration and serous effusions. Diagn Cytopathol. 2009; 37:86-90.
32. Fetsch PA, Simsir A, Brosky K, Abati A. Comparison of three commonly used cytologic preparations in effusion immunocytochemistry. Diagn Cytopathol. 2002;26:61-66.
33. Zito FA, Gadaleta CD, Salvatore C, et al. A modified cell block technique for fine needle aspiration cytology. Acta Cytol. 1995;39:93-99.
34. Krogerus LA, Andersson LC. A simple method for the preparation of paraffin-embedded cell blocks from fine needle aspirates, effusions and brushings. Acta Cytol. 1988;32:585-587.
35. Nathan NA, Narayan E, Smith MM, Horn MJ. Cell block cytology. Improved preparation and its efficacy in diagnostic cytology. Am J Clin Pathol. 2000;114:599-606.
36. Kaneko C, Kobayashi TK, Hasegawa K, Udagawa Y, Iwai M. A cell-block preparation using glucomannan extracted from Amorphophallus konjac. Diagn Cytopathol. 2010;38: 652-656.
37. Munfus-McCray D, Harada S, Adams C, et al. EGFR and KRAS mutations in metastatic lung adenocarcinomas. Hum Pathol. 2011;42:1447-1453.
38. Mohamed S, Yasufuku K, Nakajima T, et al. Analysis of cell cycle-related proteins in mediastinal lymph nodes of patients with N2-NSCLC obtained by EBUS-TBNA: relevance to chemotherapy response. Thorax. 2008;63:642-647.
39. Bepler G, Bequm M, Simon GR. Molecular analysis-based treatment strategies for non-small cell lung cancer. Cancer Control. 2008;15:130-139.